Should All MPN Patients Undergo Molecular Testing?

Dr. Gabriela Hobbs discusses the necessity of molecular testing for myeloproliferative neoplasm (MPN) patients, including the pros and cons of this in-depth testing for patients with polycythemia vera (PV) and…

What Are the Long-Term Effects of JAK Inhibitors?

https://vimeo.com/780871837 MPN expert Dr. Gabriela Hobbs discusses what researchers know about the long-term safety of JAK inhibitors and options for patients if the treatment loses effectiveness over time. Dr. Gabriela…

Advances in Myelofibrosis Research

What are the recent developments in the study and advancement of myelofibrosis treatment? MPN researcher Dr. Gabriela Hobbs discusses ongoing clinical trials for new JAK inhibitors, BET inhibitors, and anemia…

Advances in Polycythemia Vera Research

What are the recent developments in the study and advancement of care for patients with polycythemia vera (PV)? Dr. Gabriela Hobbs reviews recently approved PV treatments as well as those…

Advances in Essential Thrombocythemia Research

Are there new treatment developments for patients with essential thrombocythemia (ET)? Dr. Gabriela Hobbs shares an update on ET therapies in clinical trials and discusses when it might be appropriate…

How MPN Researchers Collaborate to Advance Patient Care

https://vimeo.com/780872752 MPN specialist and researcher Dr. Gabriela Hobbs discusses how collaboration and data sharing among researchers around the world impact MPN treatment advances. Dr. Gabriela Hobbs is a hematology-oncology physician…

Expert Perspective | Promising MPN Research

https://vimeo.com/779450519 What’s the latest in promising MPN research news? Dr. Angela Fleischman shares an update about treatment research and discusses the importance of clinical trial participation. Dr. Angela Fleischman is…

Resources for Accessing MPN Clinical Trials

https://vimeo.com/779450853 What are credible resources for accessing MPN clinical trials? Dr. Angela Fleischman shares credible resources for MPN patients and advice for inquire about clinical trial participation. Dr. Angela Fleischman…

Share On:

Facebook
Twitter
LinkedIn